Mei Zhang
Yunnan Key Laboratory Of Southern Medicine Utilization, 1076 Yuhua Road
Kunming, 650500, China
Kunming, 650500, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Endogenous Metabolite TDCA Ameliorates LPS-Driven Liver Injury via Modulation of Caspase-11/GSDMD-Mediated Pyroptosis.
Journal: International journal of molecular sciences
Published: December 26, 2025
Shenling Jianpiwei formula ameliorates metabolic associated fatty liver disease through modulation of the gut microbiota and attenuation of LPS-mediated inflammation.
Journal: Fitoterapia
Published: May 21, 2025
Poria cocos-Derived Exosome-like Nanovesicles Alleviate Metabolic Dysfunction-Associated Fatty Liver Disease by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome Activation.
Journal: International journal of molecular sciences
Published: January 25, 2025
Combining Serum Pharmacochemistry and Metabolomics to Characterize the Synergistic Compatibility Principle of Polygonati Rhizoma and Angelicae Sinensis Radix for MAFLD Mitigation.
Journal: Current pharmaceutical design
Published: January 07, 2025
In vivo identification of bioactive components of Poria cocos for adjusting mitochondria against metabolic dysfunction-associated fatty liver disease.
Journal: Heliyon
Published: March 07, 2024
Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway.
Journal: Frontiers in pharmacology
Published: February 24, 2023
Compatibility of Polygonati Rhizoma and Angelicae Sinensis Radix enhance the alleviation of metabolic dysfunction-associated fatty liver disease by promoting fatty acid β-oxidation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 26, 2023
In vivo recognition of bioactive substances of Polygonum multiflorum for protecting mitochondria against metabolic dysfunction-associated fatty liver disease.
Journal: World journal of gastroenterology
Published: September 07, 2022
In vivo identification of the pharmacodynamic ingredients of Polygonum cuspidatum for remedying the mitochondria to alleviate metabolic dysfunction-associated fatty liver disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 07, 2022
Distinct metabonomic signatures of Polygoni Multiflori Radix Praeparata against glucolipid metabolic disorders.
Journal: The Journal of pharmacy and pharmacology
Published: July 19, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026